TGFB1 and cancer: The mouse model data therefore suggest that anti-TGFβ antibodies can promote metastasis by interfering with metastasis-suppressive effects of TGFβ on the tumor parenchyma and that tumor-suppressive responses to TGFβ may be retained and dominant in some instances of advanced metastatic breast cancer, and possibly other cancers [8].